Newegg Commerce, Inc. NEGG
and distributing medical devices. We have been focusing on developing respiratory and oxygen homecare products in particular since
by other companies. We broaden our product portfolio through distribution agreements with international manufacturers, and most
of the products we distribute are imported. Our distribution offerings are mostly equipment used in the operating room, the intensive
care unit ("ICU") and the emergency room.
Last close
15.32
2026-09-04
Market cap
$321.3M
2025-12-31 share count
52-week range
12.50 - 96.29
Valuation FY2025 figures against the last close
P/S0.2x
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-0.24
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.44B | $1.24B | $1.50B | $1.72B | $2.38B | $2.11B | $1.53B | $559.4K | $882.0K | $13.1M |
| Cost of revenue | $177.3M | $166.3M | $215.2M | $224.3M | $140.0M | $135.8M | $1.37B | $757.9K | $1.7M | $17.2M |
| Gross profit | $168.5M | $131.5M | $167.6M | $216.6M | $326.0M | $273.6M | $164.9M | -$198.5K | -$774.0K | -$4.1M |
| SG&A | $178.0M | $183.0M | $238.6M | $266.2M | $292.5M | $250.2M | $229.2M | $3.7M | $3.2M | $4.2M |
| Operating income | -$9.5M | -$51.6M | -$71.1M | -$49.5M | $33.5M | $23.4M | -$36.0M | -$9.3M | -$5.1M | -$9.1M |
| Interest expense | $1.0M | $952.0K | $2.5M | $685.0K | $612.0K | $664.0K | $2.9M | — | — | $29.2K |
| Pre-tax income | -$2.9M | -$44.6M | -$61.7M | -$43.3M | $30.5M | -$3.2M | -$4.5M | -$8.9M | -$5.1M | -$9.7M |
| Income tax | $2.0M | $1.3M | $2.7M | $14.1M | $5.8M | — | — | — | — | $95.0K |
| Net income | -$4.9M | -$43.3M | -$59.0M | -$57.4M | $36.3M | -$30.4M | $17.0M | -$8.9M | -$5.1M | -$9.7M |
| EPS, basic | -0.24 | -2.25 | -3.12 | -3.08 | 0.10 | 0.08 | -0.05 | -4.05 | -0.30 | -0.93 |
| EPS, diluted | -0.24 | -2.25 | -3.12 | -3.08 | 0.08 | 0.08 | -0.05 | -4.05 | -0.30 | -0.93 |
| Shares, diluted (wtd. avg.) | $20.1K | $19.3K | $18.9K | $18.7K | $432.2K | $385.0M | $363.3M | $17.6M | $17.3M | $10.4M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $107.8M | $96.3M | $102.5M | $123.5M | $104.3M | $157.7M | $22.8K | $477.3K | $6.8M | $10.8M |
| Receivables | $62.4M | $64.4M | $80.4M | $83.5M | $62.4M | $64.8M | $61.8K | $92.1K | $9.7K | $78.1K |
| Inventory | $166.3M | $98.5M | $136.2M | $156.0M | $245.1M | $182.1M | $1.1M | $1.3M | $2.2M | $136.9K |
| Total current assets | $360.6M | $283.6M | $344.5M | $390.8M | $439.0M | $428.6M | $1.7M | $2.7M | $9.8M | $11.3M |
| Property, plant and equipment | $45.0M | $51.2M | $61.5M | $45.1M | $50.1M | $46.5M | $656.8K | $1.3M | $531.5K | $1.4M |
| Other intangibles | — | — | — | — | — | — | — | — | $3.7M | $3.8M |
| Total assets | $468.9M | $407.3M | $499.0M | $542.1M | $626.6M | $557.5M | $2.3M | $5.7M | $15.6M | $16.6M |
| Accounts payable | $160.3M | $148.3M | $206.6M | $207.1M | $220.8M | $241.5M | $226.2K | $234.4K | $47.9K | $72.5K |
| Short-term debt | — | — | $268.0K | $269.0K | $293.0K | $281.0K | $1.2M | — | $1.5M | — |
| Total current liabilities | $256.5M | $243.6M | $296.5M | $309.8M | $356.3M | $388.1M | $3.2M | $1.5M | $2.7M | $1.1M |
| Long-term debt | — | — | $1.1M | $1.4M | $1.8M | $2.1M | — | — | — | — |
| Total liabilities | $308.2M | $301.2M | $369.7M | $386.9M | $444.3M | $430.0M | $3.6M | $2.6M | $4.4M | $2.6M |
| Retained earnings | -$178.9M | -$174.0M | -$130.7M | -$71.7M | -$14.3M | -$50.5M | -$44.6M | -$40.2M | -$31.2M | -$26.1M |
| Total equity | $160.7M | $106.1M | $129.4M | $155.2M | $182.3M | $127.5M | $92.0M | -$63.3M | $11.2M | $13.9M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$27.0M | -$821.0K | -$3.8M | $20.5M | -$53.3M | $84.5M | -$10.1M | -$3.6M | -$5.4M | -$2.8M |
| Depreciation and amortisation | $7.6M | $10.7M | $13.4M | $11.0M | $10.8M | $9.1M | $10.7M | $827.6K | $1.3M | $1.2M |
| Stock-based compensation | $21.7M | $27.3M | $33.7M | $33.9M | $6.3M | $1.6M | $744.0K | $944.9K | $479.2K | $947.5K |
| Capital expenditure | $2.7M | $3.6M | $30.3M | $9.2M | $13.8M | $6.2M | $10.3M | — | — | — |
| Investing cash flow | $105.0K | $2.4M | -$14.3M | -$3.8M | -$13.8M | -$5.2M | $84.7M | -$6.2M | -$1.7M | -$636.1K |
| Financing cash flow | $35.6M | -$6.1M | $1.6M | $1.5M | $12.7M | -$1.7M | -$49.7M | $3.7M | $3.0M | $13.7M |
| Buybacks | — | $3.5M | — | — | — | — | — | — | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-048633.
Others in SIC 5990
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| ULTA | Ulta Beauty, Inc. | $24.12B | 22.0x | 9.7% |
| BBWI | Bath & Body Works, Inc. | $3.93B | 6.3x | -0.2% |
| SBH | Sally Beauty Holdings, Inc. | $1.56B | 8.8x | -0.4% |
| WOOF | Petco Health & Wellness Company, Inc. | $771.2M | 90.0x | -2.5% |
| TITN | Titan Machinery Inc. | $617.0M | — | -10.2% |
| SGU | STAR GROUP, L.P. | $418.0M | — | 1.0% |
| FLWS | 1 800 FLOWERS COM INC | $239.0M | — | -8.0% |
| RENT | Rent the Runway, Inc. | $127.2M | 2.0x | 7.6% |